Author:
Saadi Dina G.,EL-Komy Mohamed H.M.,Khedr Hadeer,Shawky Nevine,Hegazy Amira Aly,Azzazi Yousra,AlOrbani Aya M.
Reference5 articles.
1. Roflumilast (daliresp): a novel phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease;Baye;Pharm Ther,2012
2. Roflumilast for chronic plaque psoriasis;Cordoro;JAMA,2022
3. International Psoriasis Council Board Members and Councilors. Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council;Strober;J Am Acad Dermatol,2020
4. Scalp psoriasis;Wozel;JDDG,2011
5. Efficacy and safety of oral roflumilast for moderate-o-severe psoriasis—a randomized controlled trial (PSORRO);Gyldenløve;Lancet Reg Health Eur,2023
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献